Research Suggests that a type of allergy medicine might help with lung cancer Treatment – Lung Cancer Blog
The researchers at the Icahn School of Medicine at Mount Sinai have found an allergy pathway that, when blocked, could unlease anti-tumor immunity in mouse models of NSCLC (non-small cell lung cancer). This study shows that an allergy route can activate antitumor immunity. These findings were published published in the December 6 issue of Nature.
